Nonnucleoside pyrrolopyrimidines with a unique mechanism of action against human cytomegalovirus - Wikidata - awgldk - TriplyDB

Nonnucleoside pyrrolopyrimidines with a unique mechanism of action against human cytomegalovirus

Nonnucleoside pyrrolopyrimidines with a unique mechanism of action against human cytomegalovirus

http://www.wikidata.org/entity/Q28343467

about

Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activity Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidazole nucleosides Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication.Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides.

P2860

Q28353356-2337A5ED-639A-4597-807C-0E77C30F7954 Q34111307-11EC1532-5BC4-4736-BCDD-868103A81196 Q35124909-66145F8F-506B-47C6-B79C-E0A6FF2258DB Q36086432-64ACBD78-79D4-4B9F-8EB2-52BFF2A3BDC2 Q37568962-16BF698C-56D1-4513-8104-842CABF035B2 Q40334600-43C1331B-ADCD-472E-B342-57095E5CCDF2 Q47095447-4419D792-EF8A-4EAD-BD34-A7D8C0C66C4B

P2860

Nonnucleoside pyrrolopyrimidines with a unique mechanism of action against human cytomegalovirus

http://www.wikidata.org/entity/Q28343467

description

1999 nî lūn-bûn

@nan

1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Nonnucleoside pyrrolopyrimidin ...... against human cytomegalovirus

@ast

Nonnucleoside pyrrolopyrimidin ...... against human cytomegalovirus

@en

Nonnucleoside pyrrolopyrimidin ...... against human cytomegalovirus

@nl

type

label

Nonnucleoside pyrrolopyrimidin ...... against human cytomegalovirus

@ast

Nonnucleoside pyrrolopyrimidin ...... against human cytomegalovirus

@en

Nonnucleoside pyrrolopyrimidin ...... against human cytomegalovirus

@nl

prefLabel

Nonnucleoside pyrrolopyrimidin ...... against human cytomegalovirus

@ast

Nonnucleoside pyrrolopyrimidin ...... against human cytomegalovirus

@en

Nonnucleoside pyrrolopyrimidin ...... against human cytomegalovirus

@nl

P1433

Q28343467-50392C13-0748-4AC7-AFAF-FAC20509EE51

P1476

Q28343467-D88D5E28-1284-499E-9E35-7F9E17623323

P2093

Q28343467-0DB2321A-B0DD-47CC-881C-6AAF1B7DF798

Q28343467-0EDB819E-3ABA-4312-8999-D755C89D574E

Q28343467-3171E038-2265-4375-B928-5699482D75FF

Q28343467-73EC800A-272C-4B34-8613-5376F771AF4C

Q28343467-E3A63B21-64AB-4B64-A40A-75D33E25DB0F

Q28343467-F36D37C9-5E5E-48C7-8F06-AECAFD100EA1

Q28343467-F7F011FF-7B93-4B68-A503-8122443F6761

P2860

Q28343467-045D6A0F-2027-440B-A732-F654D2D7C5A5

Q28343467-0D648E39-202B-477F-B700-E7924C1601EF

Q28343467-1D23B11E-C4CD-4C01-B6E3-8E33404D20D5

Q28343467-2F5BD163-D3E4-468E-A0BE-79A9B58F5167

Q28343467-33CEA6BB-22BA-4A80-8116-D849A22E7557

Q28343467-3E06318D-7049-490E-9BB5-83C87AFABFDE

Q28343467-3F767838-E5DD-4502-8E66-020685066424

Q28343467-43562543-A1CD-47FD-A9B3-5CA4F73C8411

Q28343467-463F45E3-3272-47F1-B67F-74F746512AF0

Q28343467-4B41689C-DC97-4284-86CF-030A3933D3F1

P304

Q28343467-27665D8A-1C9A-4D3D-800C-CDC6168C5FCD

P31

Q28343467-CD9C646F-5997-48FF-BF60-445184ECB911

P356

Q28343467-64130105-9E95-44B3-A356-00F23B18A554

P407

Q28343467-3E5A9DB6-FDCA-4F87-BEC9-676F6F461ECB

P433

Q28343467-B06B0E51-6F8B-40E7-88EC-E4E77F449F7E

P478

Q28343467-5CDB86F9-327D-42B4-9736-25506160FE89

P577

Q28343467-9F4DF471-9DF1-47E6-A0EF-B28684D3592E

P698

Q28343467-844EADAF-9692-4C4D-BDE8-665138B1E8A3

P921

Q28343467-6896D27F-74A1-44BE-839C-3649D05AC6AC

P932

Q28343467-8C63F5B3-B878-4BF6-A412-F52423EFD023

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Nonnucleoside pyrrolopyrimidin ...... against human cytomegalovirus

@en

P2093

D G Sweier

http://www.w3.org/2001/XMLSchema#string

J C Drach

http://www.w3.org/2001/XMLSchema#string

J G Jacobson

http://www.w3.org/2001/XMLSchema#string

J M Breitenbach

http://www.w3.org/2001/XMLSchema#string

L B Townsend

http://www.w3.org/2001/XMLSchema#string

M R Nassiri

http://www.w3.org/2001/XMLSchema#string

T E Renau

http://www.w3.org/2001/XMLSchema#string

P2860

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

Design, synthesis, and studies on the structure activity relationships of certain pyrrolo[2,3-d]pyrimidine nucleosides and structurally related analogs as potential antineoplastic and antiviral agents

Improved synthesis and biological evaluation of an acyclic thiosangivamycin active against human cytomegalovirus

Synthesis and antiviral activity of some 7-[(2-hydroxyethoxy)methyl]pyrazolo[3,4-d]pyrimidine analogues of sangivamycin and toyocamycin

Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitors of human cytomegalovirus

Inhibition of human cytomegalovirus in culture by alkenyl guanine analogs of the thiazolo[4,5-d]pyrimidine ring system

Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival.

Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine

Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant.

Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

P304

1888-1894

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.43.8.1888

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10428908

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

89386

http://www.w3.org/2001/XMLSchema#string